CONGRESS GUIDE

Recommendations

Info

ERS International Congress 2016 DETAILED PROGRAMME MONDAY 05 SEPTEMBER, 2016 OA1805 Effect of continuous positive airway pressure on blood pressure and the metabolic profile of women with obstructive sleep apnoea. A randomized-controlled trial Francisco Campos-Rodriguez (Seville, Spain), Francisco Campos-Rodriguez, Nuria Reyes-Nuñez, Jose Cordero-Guevara, Monica Gonzalez-Martinez, Carmen Carmona-Bernal, Bernabe Jurado-Gamez, Fernanda Troncoso-Acevedo, Araceli Araceli Abad-Fernandez, Joaquin Teran-Santos, Julian Caballero-Rodriguez, Mercedes Martin-Romero, Ana Encabo- Motiño, Miguel A. Martinez-Garcia, Lirios Sacristan-Bou, Javier Navarro-Esteva, Maria Somoza-Gonzalez, Fernando Masa, Maria A. Sanchez-Quiroga, Beatriz Jara-Chinarro, Belen Orosa-Bertol, Felix del Campo-Matias OA1806 Effect of positive airway pressure on diastolic function in coronary artery disease patients with non-sleepy obstructive sleep apnea Yüksel Peker (Istanbul, Turkey), Yüksel Peker, Helena Glantz, Erik Thunström, Cecilia Wallentin Guron, Harun Uzel, Mustafa Saygin, Johan Herlitz, Magnus Johansson Room K Session 333 08:30 - 10:30 Oral Presentation: IPF treatment I Chairs : Venerino Poletti (Forlì, Italy), Athol Wells (London, United Kingdom) OA1807 LATE-BREAKING ABSTRACT: Simtuzumab in idiopathic pulmonary fibrosis: Results of a randomized clinical trial Ganesh Raghu (Seatle, United States of America), Ganesh Raghu, Kevin Brown, Harold Collard, David Lederer, Fernando Martinez, Paul Noble, Jin Woo Song, Athol Wells, Timothy Whelan, Emmanuel Moreau, Scott Patterson, Selina Bayly, Jason Chien, Jennifer Zhang, Thomas O’Riordan OA1808 OA1809 OA1810 OA1811 OA1812 OA1813 Long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis of 4 clinical trials Paul Noble (Los Angeles, United States of America), Paul Noble, Carlo Albera, Lisa Lancaster, Phillip Hormel, Henry Hulter, Ulrich Costabel Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment Paul Noble (Los Angeles, United States of America), Paul Noble, Carlo Albera, Klaus-Uwe Kirchgaessler, Frank Gilberg, Ute Petzinger, Ulrich Costabel Annual rate of FVC decline in patients with IPF treated with pirfenidone: Pooled analysis from 3 pivotal studies Marilyn K. Glassberg (Miami, United States of America), Paul Noble, Carlo Albera, Willis Chou, Ulrich Costabel, Bann-mo Day, Ian Glaspole, Marilyn Glassberg, Lisa Lancaster, David Lederer, Steven Nathan, Carlos Pereira, John Stauffer, Jeffrey Swigris Effect of baseline composite physiologic index on benefit of nintedanib in IPF Athol Wells (London, United Kingdom), Athol Wells, Jürgen Behr, Wibke Stansen, Susanne Stowasser, Toby Maher Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) Ulrich Costabel (ESSEN, Germany), Ulrich Costabel, Carlo Albera, Lisa Lancaster, Phillip Hormel, Henry Hulter, Paul Noble Analysis of patients with idiopathic pulmonary fibrosis (IPF) with percent predicted forced vital capacity (FVC)
ERS International Congress 2016 DETAILED PROGRAMME MONDAY 05 SEPTEMBER, 2016 PA1817 PA1818 PA1819 PA1820 PA1821 PA1822 PA1823 PA1824 PA1825 PA1826 PA1827 PA1828 PA1829 PA1830 Deficiency of immunoproteasome subunit LMP2 increases alternative polarization of alveolar macrophages Ilona Kammerl (Munich, Germany), Ilona Kammerl, Shanze Chen, Martin Irmler, Johannes Beckers, Oliver Eickelberg, Silke Meiners, Tobias Stöger Antiinflammatory properties of PAH drugs Kathrin Watzinger (Innsbruck, Austria), Kathrin Watzinger, Ivan Tancevski, Thomas Sonnweber, Judith Löffler-Ragg Aberrant airway epithelial differentiation resulting from cigarette smoke exposure leads to loss of constitutive antimicrobial peptide and protein (AMP) expression Pieter S. Hiemstra (Leiden, Netherlands), Pieter S. Hiemstra, Gimano D. Amatngalim, Jasmijn A. Schrumpf, Fernanda Dishchekenian, Tinne C.J. Mertens, Dennis K. Ninaber, Abraham C. van der Linden, Christian Taube, Anne M. van der Does Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control Kurt Racke (BONN, Germany), Kurt Racke, Margarita Fuhrmann, Uwe R. Juergens, Soni Pulamsetti, Werner Seeger Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Lisette I.Z. Kunz (Amsterdam, Netherlands), Lisette I.Z. Kunz, Nick H.T. Ten Hacken, Therese S. Lapperre, Wim Timens, Huib A.M. Kerstjens, Annemarie van Schadewijk, Judith M. Vonk, Jacob K. Sont, Jiska B. Snoeck-Stroband, Dirkje S. Postma, Peter J. Sterk, Pieter S. Hiemstra Identification of Ki67 + ’monocytic’ cells within the lungs Arjun Ravi (Greater Manchester, United Kingdom), Arjun Ravi, Sarah Mason, Simon Lea, Umme Kolsum, George Booth, Jorgen Vestbo, Dave Singh Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema Tetsuo Fujita (Chiba, Japan), Tetsuo Fujita, Kento Yoshioka, Hiroki Umezawa, Kensuke Tanaka, Yusuke Naito, Masahiko Hatano, Toshinori Nakayama, Koichiro Tatsumi, Yoshitoshi Kasuya Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages Jamil Jubrail (Paris, France), Jamil Jubrail, Katy Montauban, Pierre Regis-Burgel, Nisha Kurian, Florence Niedergang Telomere shortening in type II pneumocytes relates to idiopathic pulmonary fibrosis Aernoud van Batenburg (Nieuwegein, Netherlands), Aernoud van Batenburg, Reinier Snetselaar, Roel Goldschmeding, Jan Grutters, Karin Kazemier, Coline van Moorsel Eosinophil-induced airway smooth muscle cells remodeling is attenuated by blocking of RGD-binding integrins in asthma Andrius Januskevicius (Kaunas, Lithuania), Andrius Januskevicius, Simona Lavinskiene, Reinoud Gosens, Ieva Janulaityte, Deimante Hoppenot, Laura Tamasauskiene, Virginija Kalinauskaite-Zukauske, Raimundas Sakalauskas, Kestutis Malakauskas Neutrophil vascular endothelial growth factor (VEGF) as a driving force for angiogenesis in bronchiectasis? Christopher Cole (Middlesbrough, United Kingdom), Christopher Cole, Sonya Carnell, Kasim Jiwa, Jodie Birch, Katy Hester, Chris Ward, John Simpson, Anthony De Soyza Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD Pawan Sharma (Glebe, Australia), Dia Xenaki, Deepak Deshpande, Brian Oliver, Pawan Sharma Thymic stromal lymphopoietin (TSLP) in naturally occurring asthma exacerbations in adults Asger Bjerregaard (HILLERØD, Denmark), Asger Bjerregård, Svetlana Baltic, Lucy Barrett, Phillip Thompson, Vibeke Backer, Markus Fally, Ingrid Laing, Siew-Kim Khoo, Peter Le Souëf, Celeste Porsbjerg The appearance and distribution of inflammatory, anti-inflammatory and regulatory interleukins in relatively healthy lung tissue Zane Vitenberga (R ga, Latvia), Zane Vitenberga, Mara Pilmane PA1831 IL-23 is essential to the development of elastase-induced pulmonary inflammation and emphysema Utako Fujii (Okahama, Japan), Utako Fujii, Nobuaki Miyahara, Akihiko Taniguchi, Daisuke Morichika, Naohiro Oda, Koichi Waseda, Etsuko Kurimoto, Mikio Kataoka, Akihiko Yoshimura, Arihiko Kanehiro, Mitsune Tanimoto Room ICC Capital Suite 12 Session 335 08:30 - 10:30 Poster Discussion: Assessing lower airway inflammation with different tools Chairs : Petros Bakakos (ATHENS, Greece), Florence Schleich (Liège, Belgium) 129 26.08.2016
Page 1:
HELP SHAPE THE FUTURE OF RESPIRATOR
Page 4 and 5:
WELCOME FROM THE CONGRESS CHAIRS ER
Page 6 and 7:
ERS LONDON 2016 Data scanning syste
Page 8 and 9:
MAPS ERS LONDON 2016 ■ CONGRESS M
Page 10 and 11:
MAPS ERS LONDON 2016 ■ EXHIBITION
Page 12 and 13:
ERS MAPSWORLD VILLAGE ERS LONDON 20
Page 14 and 15:
INVITATION JOIN US AT THE OPENING C
Page 16 and 17:
CONGRESS RESOURCES AREA Te Congress
Page 18 and 19:
ERS-SPLF Joint Session Saturday 3 S
Page 20 and 21:
ERS-CTS Joint Session Saturday 3 Se
Page 22 and 23:
PROGRAMME AT A GLANCE
Page 24 and 25:
ERS International Congress 2016 OUT
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
WORLD VILLAGE SESSIONS
Page 44 and 45:
PROGRAMME DETAILS
Page 46 and 47:
ERS International Congress 2016 DET
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
ERS International Congress 2016 Roo
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
ERS International Congress 2016 T-0
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123: ERS International Congress 2016 DET
Page 144 and 145: ERS International Congress 2016 Pla
Page 148 and 149: ERS International Congress 2016 Roo
Page 166 and 167: ERS International Congress 2016 ICC
Page 182 and 183: ERS International Congress 2016 Pla
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
ERS International Congress 2016 Pla
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
ERS International Congress 2016 13:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
ERS International Congress 2016 Pla
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
ERS International Congress 2016 WOR
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
ERS International Congress 2016 IND
Page 386 and 387:
Page 388 and 389:
INDUSTRY SPONSORED SESSIONS DISCLAI
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
CHAIR AND COORDINATOR INDEX Name, S
Page 410 and 411:
CHAIR AND COORDINATOR INDEX S., 456
Page 412 and 413:
SPEAKER INDEX 4753, 4758, 4759 GIBS
Page 414 and 415:
SPEAKER INDEX ZAR H., 1734 ZAVORSKY
Page 416 and 417:
AUTHOR INDEX AKHTER S., PA1020, 118
Page 418 and 419:
AUTHOR INDEX ARAUJO SILVA C., PA136
Page 420 and 421:
AUTHOR INDEX 4323, 4866, 4869 BARBA
Page 422 and 423:
AUTHOR INDEX BILTON D., PA2633, PA4
Page 424 and 425:
AUTHOR INDEX BROWN M., PA5047 BROWN
Page 426 and 427:
AUTHOR INDEX PA2759 CASTIGLIA D., P
Page 428 and 429:
AUTHOR INDEX ALVAREZ B., PA1034 CIM
Page 430 and 431:
AUTHOR INDEX D’ORAZIO C., OA1489,
Page 432 and 433:
AUTHOR INDEX DEVRAJ M., PA2689 DEWA
Page 434 and 435:
AUTHOR INDEX EL ANDALOUSSI M., PA25
Page 436 and 437:
AUTHOR INDEX PA2634, PA2636, 3266,
Page 438 and 439:
AUTHOR INDEX GARCIA MOYANO M., PA23
Page 440 and 441:
AUTHOR INDEX GORHAM J., PA2820 GORI
Page 442 and 443:
AUTHOR INDEX HANIBUCHI M., PA778 HA
Page 444 and 445:
AUTHOR INDEX HOLMES L., PA4101, PA4
Page 446 and 447:
AUTHOR INDEX JADDOE V., PA3134 JADH
Page 448 and 449:
AUTHOR INDEX KANG B., PA1160, 2485
Page 450 and 451:
AUTHOR INDEX KJELDGAARD P., PA1125,
Page 452 and 453:
AUTHOR INDEX KUNA P., OA256, PA964,
Page 454 and 455:
AUTHOR INDEX PA5096 LEPEJ D., PA129
Page 456 and 457:
AUTHOR INDEX PA1311 MACEDO C., PA25
Page 458 and 459:
AUTHOR INDEX MARTÍNEZ-MEMIJE R., P
Page 460 and 461:
AUTHOR INDEX MIKURA S., PA4847 MILA
Page 462 and 463:
AUTHOR INDEX MOYA A., PA3762 MOYA A
Page 464 and 465:
AUTHOR INDEX NIKOLETOU D., PA1368 N
Page 466 and 467:
AUTHOR INDEX PA1569 OUPADIA S., PA2
Page 468 and 469:
AUTHOR INDEX OA1802, PA2083, PA2373
Page 470 and 471:
AUTHOR INDEX PPATHANASSIOU E., PA41
Page 472 and 473:
AUTHOR INDEX PA4311, PA4325 RIBEIRO
Page 474 and 475:
AUTHOR INDEX SABOGAL PINEROS Y., PA
Page 476 and 477:
AUTHOR INDEX SCHMIDT A., PA902 SCHM
Page 478 and 479:
AUTHOR INDEX SIMIDCHIEV A., PA300 S
Page 480 and 481:
AUTHOR INDEX STANCHEVA G., PA2854,
Page 482 and 483:
AUTHOR INDEX PA4357, PA4359 TAN L.,
Page 484 and 485:
AUTHOR INDEX TRIEBNER K., 629, OA49
Page 486 and 487:
AUTHOR INDEX PA601, PA1825, 2903, 3
Page 488 and 489:
AUTHOR INDEX PA3864, 4501, 4856 WAL
Page 490 and 491:
AUTHOR INDEX YAMAMOTO A., PA569, PA
show all

CONGRESS GUIDE

Create successful ePaper yourself

Delete template?

Save as template?